Work

BIMZELX® (Bimekizumab-bkzx) Injection, for Subcutaneous Use.

Year: 2024

Type: article

Source: PubMed

Authors: Aditya K Gupta, Avantika Mann, Kimberly Vincent, William Abramovits

Institutions: University of Toronto, Mediprobe Research (Canada), University of North Texas, Baylor Scott & White Health, The University of Texas Southwestern Medical Center

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403662848

FWCI:

Cites:

Cited by:

Related to: 10